Team-based Interdisciplinary Cancer Research Training Program
基于团队的跨学科癌症研究培训计划
基本信息
- 批准号:10378145
- 负责人:
- 金额:$ 27.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
TEAM-BASED INTERDISCIPLINARY CANCER RESEARCH TRAINING PROGRAM
PROJECT SUMMARY/ABSTRACT
In advancing innovative ways to address complex cancer challenges, there is a growing trend to bring together
scientists with knowledge and perspectives from different disciplines. The emphasis on developing relationships
across scientific disciplines and adopting collaborative interdisciplinary approaches to scientific discovery has
been recognized and shown to lead to significant advances in our fundamental understanding of cancer and its
clinical management. In addition, it is abundantly clear that such advances rarely occur in isolation but typically
represent team-based research endeavors. We believe that early exposure of trainees to interdisciplinary
education and training coupled with team-based learning and research environments will better position them
for successful careers in any area of cancer research. At present, there are no existing NCI-funded T32 programs
devoted to team-based training. This concept is emphasized in our proposed Team-based Interdisciplinary
Cancer Research Training (TICaRT) Program. The Program is based on four premises: 1) interdisciplinary
training in team science will be critical in preparing future generations of cancer scientists; 2) team-based
research translates into an improved training environment by providing trainees with access to scientists in
different disciplines; 3) Florida needs a continuous supply of highly-trained cancer researchers including women,
underrepresented minorities and individuals with disabilities; and 4) program graduates must have the skills to
translate their knowledge and experience to achieve successful cancer research careers in academic, industry,
or government positions. Our goal is to develop a cadre of outstanding independent investigators in a training
program that encompasses cancer research across disciplines and unites laboratories, trainees, and mentors in
areas, including dentistry, engineering, medicine, nursing, pharmacy, public health, veterinary medicine, and
communication. The TICaRT program capitalizes on our existing strengths at the University of Florida, including
a core of well-established and productive investigators, outstanding research facilities, an exemplary record of
collaboration, excellent institutional commitment, and a culture of successful mentorship of graduate students,
post-doctoral fellows and early stage faculty. We have assembled a cohesive group of 29 basic science and
clinical faculty from 22 departments, 9 Colleges, and 10 PhD Programs. Upon entering the TICaRT Program,
each member of the trainee team will create and implement a tailored training plan under the guidance of his/her
faculty mentors. Trainees will achieve their research and career development objectives through a combination
of didactic, research, and professional development activities. The TICaRT Program requests NCI support for 1
pre-doctoral and 3 post-doctoral trainees; support for 2 additional pre-doctoral trainees is pledged by our
institution. The TICaRT T32 is led by a Director and two Co-Directors, who will obtain input from Internal and
External Advisory Boards, and ongoing program evaluations and quality improvement will be in place to ensure
the long-term success of the trainees.
基于团队的跨学科癌症研究培训计划
项目总结/摘要
在推进创新方法以应对复杂的癌症挑战方面,
拥有不同学科知识和观点的科学家。强调发展关系
跨学科和采用跨学科协作方法进行科学发现,
已被认可并证明会在我们对癌症及其疾病的基本认识方面取得重大进展
临床管理此外,非常清楚的是,这种进步很少是孤立发生的,
代表了基于团队的研究努力。我们认为,学员早期接触跨学科
教育和培训加上以团队为基础的学习和研究环境将更好地定位他们
在癌症研究的任何领域取得成功。目前,没有任何现有的NCI资助的T32项目
致力于团队训练。这一概念在我们提出的基于团队的跨学科课程中得到了强调。
癌症研究培训计划(TICaRT)。该计划基于四个前提:1)跨学科
团队科学的培训将是培养未来几代癌症科学家的关键; 2)基于团队的
研究转化为更好的培训环境,为受训者提供接触科学家的机会,
不同的学科; 3)佛罗里达需要不断提供训练有素的癌症研究人员,包括妇女,
代表性不足的少数民族和残疾人;和4)程序毕业生必须有技能,
翻译他们的知识和经验,以实现成功的癌症研究事业在学术,工业,
或政府职位。我们的目标是培养一批优秀的独立调查员,
该计划包括跨学科的癌症研究,并将实验室,学员和导师联合起来,
领域,包括牙科,工程,医学,护理,药学,公共卫生,兽医,和
通信TICaRT计划利用了我们在佛罗里达大学的现有优势,包括
一个完善的和富有成效的研究人员的核心,优秀的研究设施,
合作,优秀的机构承诺,以及研究生成功导师的文化,
博士后研究员和早期教师。我们召集了一个由29名基础科学和
来自22个部门,9个学院和10个博士课程的临床教师。一旦进入TICaRT程序,
学员团队的每个成员将在其指导下制定并实施量身定制的培训计划,
教师导师学员将通过以下方式实现他们的研究和职业发展目标:
教学,研究和专业发展活动。TICaRT计划要求NCI支持1
博士前和3名博士后学员;我们承诺支持另外2名博士前学员
机构。TICaRT T32由一名董事和两名联席董事领导,他们将从内部和外部获取意见,
外部咨询委员会、持续的项目评估和质量改进将到位,以确保
学员的长期成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIETMAR W SIEMANN其他文献
DIETMAR W SIEMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIETMAR W SIEMANN', 18)}}的其他基金
Cancer Research Training and Education Coordination
癌症研究培训和教育协调
- 批准号:
10625752 - 财政年份:2023
- 资助金额:
$ 27.6万 - 项目类别:
Team-based Interdisciplinary Cancer Research Training Program
基于团队的跨学科癌症研究培训计划
- 批准号:
10600833 - 财政年份:2021
- 资助金额:
$ 27.6万 - 项目类别:
Hypoxia: Impact on Src Signaling and Prostate Cancer
缺氧:对 Src 信号传导和前列腺癌的影响
- 批准号:
9298599 - 财政年份:2016
- 资助金额:
$ 27.6万 - 项目类别:
Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta
靶向组织蛋白酶 L:阻止前列腺癌和乳腺癌转移的新策略
- 批准号:
8583124 - 财政年份:2013
- 资助金额:
$ 27.6万 - 项目类别:
Enhancing Radiation Therapy: Vascular Targeting Agents
增强放射治疗:血管靶向剂
- 批准号:
7035767 - 财政年份:2004
- 资助金额:
$ 27.6万 - 项目类别:
Enhancing Radiation Therapy: Vascular Targeting Agents
增强放射治疗:血管靶向剂
- 批准号:
6878629 - 财政年份:2004
- 资助金额:
$ 27.6万 - 项目类别:
Enhancing Radiation Therapy: Vascular Targeting Agents
增强放射治疗:血管靶向剂
- 批准号:
7211346 - 财政年份:2004
- 资助金额:
$ 27.6万 - 项目类别:
Enhancing Radiation Therapy: Vascular Targeting Agents
增强放射治疗:血管靶向剂
- 批准号:
6726743 - 财政年份:2004
- 资助金额:
$ 27.6万 - 项目类别:
Combining Anti Angiogenesis Strategies and Radiotherapy
结合抗血管生成策略和放射治疗
- 批准号:
6633928 - 财政年份:2001
- 资助金额:
$ 27.6万 - 项目类别:
Combining Anti-Angiogenesis Strategies and Radiotherapy
结合抗血管生成策略和放射治疗
- 批准号:
8206850 - 财政年份:2001
- 资助金额:
$ 27.6万 - 项目类别: